Buyers Want 1st Circ. To Rethink Nexium Pay-For-Delay Suit
By Eric Kroh ( December 13, 2016, 2:32 PM EST) -- Retailers and indirect purchasers of heartburn medication Nexium on Monday asked the First Circuit for a rehearing of its November decision declining to revive a pay-for-delay class action against AstraZeneca PLC and Ranbaxy Inc. over the drug....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.